JBT Marel Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a JBTM research report →
Range $165 – $175
Price Chart
About the company
Headquartered in Chicago, Illinois, and established in 1994, JBT Marel Corporation offers sophisticated technological solutions to the global food and beverage industries, with operations spanning North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. The company's core offerings include a comprehensive suite of value-added processing capabilities for the food, beverage, and health markets. These solutions cover a wide range of functions, such as chilling, mixing, grinding, injecting, blending, marinating, tumbling, flattening, forming, portioning, coating, cooking, frying, freezing, extracting, pasteurizing, sterilizing, concentrating, high-pressure processing, weighing, inspecting, filling, closing, sealing, and end-of-line material handling and packaging.
- CEO
- Brian A. Deck
- IPO
- 2008
- Employees
- 11,500
- HQ
- Chicago, IL, US
Get TickerSpark's AI analysis on JBTM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $6.04B
- P/E
- 31.34
- Fwd P/E
- 14.37
- PEG
- 0.04
- P/S
- 1.54
- P/B
- 1.35
- EV/EBITDA
- 13.97
- Div Yield
- 0.34%
- Gross Margin
- 35.55%
- Op Margin
- 7.35%
- Net Margin
- 4.89%
- ROE
- 4.31%
- ROIC
- 3.48%
Latest fiscal year · YoY change
- Revenue
- $3.80B+121.3%
- Gross Profit
- $1.33B+113.0%
- Op Income
- $189.40M
- Net Income
- $-50,500,000-159.1%
- EPS
- $-0.98-136.7%
- OCF Growth
- +46.3%
- FCF Growth
- +21.7%
- 52W High
- $170.19
- 52W Low
- $113.67
- 50D MA
- $132.35
- 200D MA
- $139.70
- Beta
- 0.94
- RSI (14)
- 33
- Avg Volume
- 569.47K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
JBT Marel delivered solid Q2 order growth and record backlog, but logistics and footprint changes pressured prepared-food margins and kept full-year guidance unchanged.· August 4, 2026
- Orders rose 10% year over year and topped $1 billion for the third straight quarter, with strong cross-selling from the JBT Marel combination.
- Q2 revenue was $981 million, up 5% year over year, while adjusted EBITDA was $168 million; prepared food and beverage revenue was flat and missed expectations because of logistics and production inefficiencies.
- Protein Solutions remained the standout, with revenue of $467 million, up 11%, and management said protein demand and poultry investment remain strong.
- Prepared Food and Beverage should improve through the back half as delayed shipments flow through and facility moves normalize; management expects a steeper Q4 ramp than Q3.
- The company kept full-year 2026 revenue and adjusted EBITDA guidance unchanged and reaffirmed its 2028 adjusted EBITDA margin target of 20%.
Q2 consolidated revenue was $981 million, up 5% year over year, with 3% organic growth and 2% from foreign exchange. Q2 adjusted EBITDA was $168 million. Protein Solutions revenue was $467 million, up 11% year over year, while Prepared Food and Beverage revenue was flat versus last year. Management said Q2 was affected by $17 million of IEEPA tariff refunds, partially offset by $4 million of higher-than-expected tariff expense tied to prior years and $5 million of accelerated long-term incentive compensation expense. They also said they were short about $20 million of revenue in the quarter, all in Prepared Food and Beverage, and that this represented a cadence shift into the back half. For Q3, they guided to 2% to 4% organic revenue growth, with a 1% FX headwind, and adjusted EBITDA margins of 17% to 17.5%. Full-year 2026 revenue and adjusted EBITDA guidance was maintained, with midpoint guidance implying 6% consolidated revenue growth and 145 basis points of adjusted EBITDA margin expansion. Adjusted EPS guidance was refined for updated depreciation, amortization, and tax assumptions.
Brian Deck emphasized that demand remains robust, calling out three straight quarters of orders above $1 billion and strong cross-selling benefits from the combination. He framed the quarter as evidence that JBT Marel can serve customers across the full protein value chain, especially poultry, and said backlog visibility and integration work support confidence in the second half and the 2028 margin target. His tone was constructive but candid: he acknowledged that prepared-food results fell short because of temporary logistics and facility-transition issues, while still describing the segment as a long-term opportunity.
Matt Meister focused on the quarter’s financial bridge and the operational factors behind margin pressure. He highlighted $179 million of year-to-date free cash flow, representing 58% conversion to adjusted EBITDA, and said leverage ended just below 2.5x, within the company’s target range after 18 months. He also said the warehouse automation restructuring should deliver about $9 million in total annual savings, including about $3 million in the second half of 2026, and that footprint optimization should generate about $25 million to $30 million of annualized savings by 2028, with roughly $4 million to $5 million embedded in the 2026 forecast.
Analysts focused on the cadence of prepared-food margins, the durability of protein margins, pricing versus inflation, order trends into 2027, factory consolidations, capital allocation, and the U.S. chicken line-speed decision. Management said about $20 million of prepared-food revenue was pushed from Q2 into the back half, and guided to sequential margin improvement in PFB from Q2 to Q3 and then another roughly 100 basis points into Q4. On protein, they said margins should be relatively flat in the back half as mix shifts toward more equipment versus aftermarket. They also said facility consolidations will be phased through the end of 2027, and that M&A is not a near-term focus while the integration continues; buybacks will be weighed against debt paydown opportunistically.
The bullish case is that demand is still strong enough to support record backlog, orders above $1 billion, and maintained full-year guidance even after a messy quarter. Management sees multiple self-help levers—cross-selling, pricing, footprint optimization, warehouse automation restructuring, and supply-chain standardization—plus strong protein demand and potential upside from a future USDA line-speed decision. They also reiterated confidence in a 20% adjusted EBITDA margin target for 2028.
The main risks are execution and timing: Q2 showed that logistics constraints, plant moves, and production inefficiencies can delay revenue and hit margins, especially in Prepared Food and Beverage. Inflation in logistics and other inputs is still outpacing some pricing recovery, and management said some leakage remained in Q2. There is also uncertainty around the pace of consolidations through 2027, the durability of poultry investment cycles, and whether weaker CPG demand or a slower recovery in AGV could offset strength in protein.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.0%
- Shares Outstanding
- 52.07M
- Float Shares
- 51.53M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Held by 354 ETFs
Biggest fund positions in JBTM by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 15, 26 | Moller Andrew James | other | 743 |
| Jun 30, 26 | Pelletier James C | other | 409 |
| Jun 1, 26 | Moller Andrew James | other | 0 |
| Mar 2, 26 | Deck Brian A | sell | 10,000 |
| Mar 3, 26 | Deck Brian A | sell | 8,634 |
| Feb 27, 26 | Siddons Mary Beth | other | 79 |
| Feb 27, 26 | Rizzolo Luiz Augusto | other | 343 |
| Feb 27, 26 | Petrie Robert James | other | 407 |
| Feb 27, 26 | Meister Matthew J | other | 476 |
| Feb 27, 26 | Deck Brian A | other | 2,508 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our JBTM coverage
Recent articles, reports, and earnings notes.

Middleby Corp. Common Stock Ex-Distribution When Issued: Bull vs. Bear
Middleby Corp. Common Stock Ex-Distribution When Issued (MIDDV) is expected to list on NASDAQ on 2026-06-26, with no price range disclosed. This is a spin-off, not a cash-raising IPO, so the key question is how the market values the standalone food-processing business once when-issued trading begins. Bull case: a pure-play industrial automation and aftermarket platform; bear case: leverage, cyclicality, and a market that has not yet set the price.

Midera Food Processing Spins Off: Pure-Play Automation Takes Shape
Midera Food Processing, Inc. Common Stock When Issued is expected to list on June 26, 2026 on NASDAQ, with the price range not disclosed. This is a spin-off, not a traditional cash-raising IPO, so the key question is how the market values the standalone food-processing platform. Bulls will focus on its scale and automation exposure; bears will focus on execution risk and the lack of disclosed pricing.
Want a deeper read on JBTM?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
JBT Marel: Mr. Market Is Overreacting
seekingalpha.com · Aug 18
JBTM Investors Have Opportunity to Join JBT Marel Corporation Fraud Investigation with SBS Law
businesswire.com · Aug 17
JBTM Investors Have Opportunity to Join JBT Marel Corporation Fraud Investigation with SBS Law
businesswire.com · Aug 17
JBTM (JBTM) Securities Investigation Notice - Levi & Korsinsky
prnewswire.com · Aug 17
Chuck Royce's Second Quarter 2026 13F: Catalyst Pharmaceuticals Reduction Leads Portfolio Shifts
gurufocus.com · Aug 14
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving JBTM (JBTM)
globenewswire.com · Aug 13
JBT Marel Corporation $JBTM Stake Cut by Cetera Investment Advisers
defenseworld.net · Aug 13
JBTM Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into JBTM (JBTM)
gurufocus.com · Aug 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.